A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2012 - Elsevier
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …
被引用次数：56 相关文章
[HTML] nih.gov

[HTML][HTML] A Novel Combined Adjuvant For Nasal Delivery Elicits Mucosal Immunity To Influenza In Aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2012 - ncbi.nlm.nih.gov
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2011 - europepmc.org
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - 2012 - cabidigitallibrary.org
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

[引用][C] A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2012 - cir.nii.ac.jp
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN)(3)
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2012 - infona.pl
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2011 - europepmc.org
Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

[引用][C] A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - 2012

[引用][C] A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging

H Asanuma, NB Zamri, S Sekine, Y Fukuyama… - Vaccine, 2012 - Elsevier Limited